Skip to main content
SpringerLink
Log in

Abiraterone-acetate/prednisone

Lack of efficacy : case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. In the presentation, prednisolone was mentioned at one place. However, prednisone is considered as suspect considering first-line AA-P treatment consisted of abiraterone acetate and prednisone.

Reference

  • Boerrigter E, et al. Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment. Molecular Oncology 15: 2453-2465, No. 9, Sep 2021. Available from: URL: https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.12933

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone-acetate/prednisone. Reactions Weekly 1937, 16 (2022). https://doi.org/10.1007/s40278-022-29696-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29696-0

Search

Navigation